Page 2 - Recurrent Stroke News Today

Until recently, clinicians had little evidence to guide their decisions about the most effective and safe treatment for the oldest patients with atrial fibrillation and recent stroke.

The observational ATTUNE study suggests that starting anticoagulation within 4 days of stroke leads to fewer new infarcts detected by imaging without an increase in hemorrhage compared with starting later.

Netherlands: In patients with mild-to-moderate carotid stenosis, carotid intraplaque hemorrhage (IPH) and total plaque volume increase the risk of transient ischemic attack or recurrent ipsilateral...

The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or TIA, on top of dual antiplatelet therapy.

More than 4 decades of research has clearly demonstrated that social isolation and loneliness carry cardiovascular risks, a new American Heart Association scientific statement concludes.

Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.

An advisory from the American Academy of Neurology on preventing recurrent stroke in symptomatic intracranial atherosclerosis recommends antiplatelets and statins but advises against stenting.

Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.

A retrospective analysis suggests that recent NOAC use is not associated with increased risk for symptomatic intracranial hemorrhage after treatment with IV alteplase for acute ischemic stroke.

The easy-to-use scoring system will allow clinicians to stratify patients with the infection by their level of risk.